Dr. Bitran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 Luther Ln
Park Ridge, IL 60068Phone+1 847-268-8200Fax+1 847-410-0051
Summary
- Dr. Jacob Bitran is an oncologist in Park Ridge, IL and is affiliated with Advocate Lutheran General Hospital. He received his medical degree from University of Illinois College of Medicine and has been in practice 46 years. He specializes in hematologic oncology and is experienced in hematologic oncology and lymphoma & myeloma.
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1977
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1975
- Rush University Medical CenterResidency, Pathology-Anatomic and Clinical, 1972 - 1973
- Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1971 - 1972
- University of Illinois College of MedicineClass of 1971
Certifications & Licensure
- CA State Medical License 1976 - Present
- IL State Medical License 1972 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- Join now to see all
Publications & Presentations
PubMed
- 173 citationsPembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.Maria-Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold, Albert Oriol, David Simpson
The Lancet. Haematology. 2019-07-18 - 10 citationsRemission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximideFreidoon Azizi, Jacob D. Bitran, Ghodratolla Javehari, Arthur L. Herbst
American Journal of Obstetrics and Gynecology. 1979-02-15 - 76 citationsDiffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction.J. Bruce Miller, Daina Variakojis, Jacob D. Bitran, Donald L. Sweet, Jeannie Kinzie
Cancer. 1981-02-15
Authored Content
- A Retrospective Study of Double-Hit Lymphomas in Elderly Patients (> 70 Years): Overall OutcomesFebruary 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: